Skip to Content

Notice

Manufacturer of Controlled Substances; Notice of Application

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 18, 2011, Aldrich Chemical Company Inc., DBA Isotec, 3858 Benner Road, Miamisburg, Ohio 45342-4304, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:Start Printed Page 72974

DrugSchedule
Gamma Hydroxybutyric Acid (2010)I
Methaqualone (2565)I
Ibogaine (7260)I
Tetrahydrocannabinols (7370)I
2,5-Dimethoxyamphetamine (7396)I
Psilocyn (7438)I
Normorphine (9313)I
Acetylmethadol (9601)I
Alphacetylmethadol except levo-alphacetylmethadol (9603)I
Normethadone (9635)I
Norpipanone (9636)I
3-Methylfentanyl (9813)I
Amphetamine (1100)II
Methamphetamine (1105)II
Methylphenidate (1724)II
Amobarbital (2125)II
Pentobarbital (2270)II
Secobarbital (2315)II
1-Phenylcyclohexylamine (7460)II
Phencyclidine (7471)II
Phenylacetone (8501)II
1-Piperidinocyclohexanecarbonitrile (8603)II
Cocaine (9041)II
Codeine (9050)II
Oxycodone (9143)II
Hydromorphone (9150)II
Benzoylecgonine (9180)II
Ethylmorphine (9190)II
Hydrocodone (9193)II
Isomethadone (9226)II
Meperidine (9230)II
Meperidine intermediate-A (9232)II
Meperidine intermediate-B (9233)II
Methadone (9250)II
Methadone intermediate (9254)II
Dextropropoxyphene, bulk, (non-dosage forms) (9273)II
Morphine (9300)II
Thebaine (9333)II
Levo-alphacetylmethadol (9648)II
Oxymorphone (9652)II

The company plans to manufacture small quantities of the listed controlled substances to produce isotope labeled standards for drug testing and analysis.

In reference to drug code 7370 the company plans to bulk manufacture a synthetic Tetrahydrocannabinol. No other activity for this drug code is authorized for this registration.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than January 27, 2012.

Start Signature

Dated: November 18, 2011.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 2011-30542 Filed 11-25-11; 8:45 am]

BILLING CODE 4410-09-P